<?xml version="1.0" encoding="UTF-8"?>
<p>Although current therapies for chronic HBV are associated with high viral suppression rates, patients generally require lifelong therapy, and true virologic clearance remains elusive. HBV management has generally been approached with viral suppression using antiviral therapies. This section will detail recent developments, including recent development of a new effective first‚Äêline antiviral and future therapeutic strategies under investigation.</p>
